About AminoChain
AminoChain is a company based in New York (United States) founded in 2022 by Caspar Barnes. AminoChain has raised $7.07 million across 1 funding round from investors including Andreessen Horowitz. AminoChain offers products and services including AminoChain Platform and Specimen Center. AminoChain operates in a competitive market with competitors including GenVault Corporation, iSpecimen, Cryoniss, PrecisionMed and ViaCell, among others.
- Headquarter New York, United States
- Founders Caspar Barnes
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.07 M (USD)
in 1 rounds
-
Latest Funding Round
$7.07 M (USD), Series A
Aug 16, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AminoChain
AminoChain offers a comprehensive portfolio of products and services, including AminoChain Platform and Specimen Center.
Technology connecting stakeholders for biospecimen donation and tracking.
Platform for discovering and acquiring biospecimens for research needs.
Funding Insights of AminoChain
AminoChain has successfully raised a total of $7.07M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.07 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AminoChain
AminoChain has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Andreessen Horowitz.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked |
Investor details for AminoChain
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AminoChain
Investment portfolio details for AminoChain
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AminoChain
Detailed financials for AminoChain
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aminochain Comparisons
Peer comparison for AminoChain
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AminoChain
AminoChain operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, Cryoniss, PrecisionMed and ViaCell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| Locked | Locked | Locked |
Provider of a biorepository of human clinical specimens
|
|
| Locked | Locked | Locked |
Provider of biobanking services for life sciences industries
|
|
| Locked | Locked | Locked |
Human biological materials for research are supplied via a biorepository.
|
|
| Locked | Locked | Locked |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
Detailed competitors of AminoChain
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aminochain
Complete news archive for AminoChain
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AminoChain
AminoChain was founded in 2022 and raised its 1st funding round 2 years after it was founded.
AminoChain is headquartered in New York, United States. It is registered at New York, New York, United States.
Caspar Barnes is the current CEO of AminoChain. They have also founded this company.
AminoChain is a funded company, having raised a total of $7.07M across 1 funding round to date.
AminoChain was founded in 2022 in New York, United States, within the blockchain and biotechnology sectors. A decentralized platform is operated to tokenize stem cell donations and provide incentives for donors. Connections are facilitated between biobanks, clinical sites, and bio-pharma companies via a bio-sample marketplace. Emphasis is given to secure tokenization processes and donor participation mechanisms.
AminoChain's top competitors include Cryoport, iSpecimen and Clean Cells.
AminoChain offers AminoChain Platform and Specimen Center.
AminoChain has 1 investor. Key investors include Andreessen Horowitz.